Serodiagnosis of human brucellosis by an indirect ELISA test using recombinant outer membrane protein 19 kDa (rOMP19) as an antigen

Immunization with a combination of recombinant Brucella abortus proteins induces T helper immune response and confers protection against wild‐type challenge in BALB/c mice

(2022) Zhiqiang Li et al.   Microbial Biotechnology

Evaluation of the Combined Use of Major Outer Membrane Proteins in the Serodiagnosis of Brucellosis

(2022) Meixue Yao et al.   Infection and Drug Resistance

Trends in the Epidemiology of Brucellosis Cases in Iran during the Last Decade

(2022) Mohammad Zeinali et al.   Iranian Journal of Public Health

Immunization With a Combination of Four Recombinant Brucella abortus Proteins Omp16, Omp19, Omp28, and L7/L12 Induces T Helper 1 Immune Response Against Virulent B. abortus 544 Infection in BALB/c Mice

(2021) Tran Xuan Ngoc Huy et al.   Frontiers in Veterinary Science

Prevalence and risk factors of human brucellosis and malaria among patients with fever in malaria-endemic areas, attending health institutes in Awra and Gulina district, Afar Region, Ethiopia

(2021) Sintayehu Mehari et al.   BMC INFECTIOUS DISEASES

Hybrid recombinant Omp 22, 25, and 31 immunodominant epitopes can be used for serodiagnosis of brucellosis

(2021) Sima Dehghani et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Associated factors in distinguishing patients with brucellosis from suspected cases

(2019) Jingjing Luo et al.   BMC INFECTIOUS DISEASES

A Systematic Review and Meta-Analysis of Epidemiology and Clinical Manifestations of Human Brucellosis in China

(2018) Rongjiong Zheng et al.   Biomed Research International

Annual trends of human brucellosis in pastoralist communities of south-western Uganda: a retrospective ten-year study

(2015) Catherine Kansiime et al.   Infectious Diseases of Poverty

Clinical Utility of A Quantitative Rose Bengal Slide Agglutination Test in the Diagnosis of Human Brucellosis in an Endemic Region

(2014) Basappa Mantur et al.   Clinical Laboratory